Surmodics Inc
NASDAQ:SRDX
Surmodics Inc
NASDAQ:SRDX
Price:
32.49 USD
-5.96%
Market Closed
Updated:
May 5, 2024
Surmodics Inc
Revenue
|
Surmodics Inc
Revenue Peer Comparison
Comparables:
BDX
BSX
SYK
ABT
ISRG
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Surmodics Inc
NASDAQ:SRDX
|
Revenue
$138.2m
|
CAGR 3-Years
13%
|
CAGR 5-Years
10%
|
CAGR 10-Years
9%
|
|
|
Becton Dickinson and Co
NYSE:BDX
|
Revenue
$19.5B
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
9%
|
|
|
Boston Scientific Corp
NYSE:BSX
|
Revenue
$14.7B
|
CAGR 3-Years
13%
|
CAGR 5-Years
8%
|
CAGR 10-Years
7%
|
|
|
Stryker Corp
NYSE:SYK
|
Revenue
$21B
|
CAGR 3-Years
13%
|
CAGR 5-Years
9%
|
CAGR 10-Years
9%
|
|
|
Abbott Laboratories
NYSE:ABT
|
Revenue
$40.3B
|
CAGR 3-Years
3%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
|
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
Revenue
$7.3B
|
CAGR 3-Years
17%
|
CAGR 5-Years
14%
|
CAGR 10-Years
13%
|
Surmodics Inc
Revenue Breakdown
Breakdown by Geography
Surmodics Inc
Surmodics Inc
Not Available
Breakdown by Segments
Surmodics Inc
Surmodics Inc
|
Total Revenue:
132.6m
USD
|
|
Royalty:
62.4m
USD
|
|
Product:
60.6m
USD
|
|
Research Development And Other:
9.6m
USD
|
See Also
What is Surmodics Inc's Revenue?
Revenue
138.2m
USD
138.2m
USD
Based on the financial report for Dec 31, 2023, Surmodics Inc's Revenue amounts to 138.2m USD.
What is Surmodics Inc's Revenue growth rate?
Revenue CAGR 10Y
9%
9%
Over the last year, the Revenue growth was 36%. The average annual Revenue growth rates for Surmodics Inc have been 13% over the past three years , 10% over the past five years , and 9% over the past ten years .
You don't have any saved screeners yet
